Verve Therapeutics
About Us
Why Cardiovascular Disease
Our Approach
Our Pipeline
Culture & Careers
Investors
Overview
News & Events
Stock Information
Corporate Governance
Financials & Filings
IR Resources
One-off injection may drastically reduce heart attack risk
Post navigation
Previous Post
Previous
With a superstar cardiologist as its CEO, new CRISPR company targets heart disease
Next Post
Next
10-year-old’s cholesterol was over 800. Can CRISPR fix the problem?
Home
About Us
Why Cardiovascular Disease
Our Approach
Our Pipeline
Culture & Careers
Investors
►
◄ Back
Overview
News & Events
Stock Information
Corporate Governance
Financials & Filings
IR Resources
Contact Us